Concord Wealth Partners’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History

Concord Wealth Partners’s Portfolio CTIC Stock Details CTIC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-3	Closed	–	–	1434
2021 Q4	$0	Buy	+3	New	+$7	﹤0.01%	1375
2021 Q1	–	Sell	-9	Closed	–	–	1094
2020 Q4	$0	Buy	+9	New	+$30	﹤0.01%	700

Other funds holding CTIC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return

Stonepine Capital Management Bend, Oregon $114M AUM 77.6% 1-Year Est. Return

Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management

Millennium Management New York $134B AUM 35.51% 1-Year Est. Return

Sofinnova Investments Menlo Park, California $2B AUM 117.41% 1-Year Est. Return

Two Sigma Investments

Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return